Business Wire

ReSound® Returns to the World’s Largest Consumer Electronics Show in Berlin to Showcase the Most Advanced Hearing Solutions

Del

ReSound returns this week to IFA, the world’s largest international consumer electronics show, to feature its award winning Smart Hearing aids and to help lead the current discussion on how to support hearing health care professionals in their task of creating highest satisfaction for people with hearing loss, during fitting process and day-to-day life. More than 500 million people worldwide suffer from hearing loss, including 13 to 15 million Germans.

Consumers and members of the news media are invited to experience ReSound Smart Hearing at the ReSound booth, found in Hall 7.2b 201.

ReSound LiNX2™ and ReSound ENZO2™ are the world’s first and only full family of advanced hearing aids with Made for iPhone capabilities and comes with the awarded ReSound Smart app free of charge in the Apple App Store, and for several Android devices in the Google Play Store. ReSound representatives will provide visitors with interactive demonstrations of the full ecosystem of ReSound Smart Hearing solutions, which allow wearers to stream sounds directly from their iPhone®, iPad®, or iPod touch® to their hearing aids.

ReSound Smart Hearing leverages ReSound’s proprietary 2.4 GHz wireless platform, allowing wearers to personalize their hearing like never before by delivering the power of direct control over hearing aid settings through the ReSound Smart app. ReSound’s industry-leading technologies put customization at the users’ fingertips, allowing wearers to make adjustments in real-time based on personal preference and listening environment.

ReSound’s full family of Smart Hearing aids improve hearing outcomes for people of all ages and for all types of hearing loss. The ReSound Smart Hearing portfolio provides solutions for children, teenagers and adults, including those with mild-to-moderate or severe-to-profound hearing loss.

“IFA is one of the most important places to feature the latest in health care innovation,” said GN Hearing CEO Anders Hedegaard. “In addition to featuring ReSound’s portfolio of Smart Hearing solutions, we will be driving the discussion on innovations in audiology and hearing care that tackle important obstacles to achieving even higher user satisfaction and more effortless, natural hearing for users of ReSound products worldwide.”

Members of the news media are encouraged to schedule an interview with company representatives.
For English speaking media: Please contact John Procter at jprocter@mcbeestrategic.com
For German speaking media: Please contact Martin Schaarschmidt at martin.schaarschmidt@berlin.de

ReSound’s revolutionary portfolio of Smart Hearing aid technology is available through a global network of hearing care professionals. Consumers can find more information by visiting www.resound.com.

About GN Hearing

GN Hearing is a leading international developer and manufacturer of innovative hearing healthcare solutions committed to let people hear more, do more and be more than they ever thought possible. The company has reinvented the hearing system with its revolutionary ReSound Smart Hearing aids that give impressive sound and personal freedom to hearing aid users through wireless smartphone and tablet connectivity. ReSound is part of GN Group comprising a unique portfolio of medical, professional and consumer sound solutions that make life sound better through its research, insights, and expertise in sound.

Contact information

ReSound
John Procter, +1-703-587-9967
jprocter@mcbeestrategic.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13Pressemelding

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21Pressemelding

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 11:38Pressemelding

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 11:00Pressemelding

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

AML BitCoin Enters Phase II of ICO15.12.2017 09:00Pressemelding

NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom